RI
SAGE

RTW Investments’s Sage Therapeutics SAGE Stock Holding History

RTW Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,002,370
Closed -$16.3M – 79
2024
Q4 		$16.3M Sell
3,002,370
-2,589,330
-46% -$15.8M 0.25% 47
2024
Q3 		$40.4M Buy
5,591,700
+111,123
+2% +$1.02M 0.58% 39
2024
Q2 		$59.5M Hold
5,480,577
– – 0.92% 31
2024
Q1 		$103M Buy
5,480,577
+283,558
+5% +$6.54M 1.52% 26
2023
Q4 		$113M Buy
5,197,019
+47,537
+0.9% +$942K 1.76% 21
2023
Q3 		$106M Buy
+5,149,482
New +$149M 2.24% 17
2019
Q1 		– Sell
-165,990
Closed -$15.9M – 53
2018
Q4 		$15.9M Buy
+165,990
New +$19M 1.46% 20

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

RTW Investments's SAGE Position: Q1 2025 in Review

RTW Investments sold out of Sage Therapeutics (SAGE) in Q1 2025, closing a stake of 3,002,370 shares — an estimated $16.3M sold.

RTW Investments first reported a position in SAGE in Q4 2018 and held it in 7 quarters. The position peaked at $113M in Q4 2023. 198 funds tracked by Wall St. Rank hold SAGE as of Q1 2025.

  • RTW Investments reported no remaining Sage Therapeutics position as of Q1 2025 after selling out during the quarter.
  • RTW Investments sold 3,002,370 Sage Therapeutics shares in Q1 2025, an estimated $16.3M.
  • RTW Investments first reported a position in Sage Therapeutics in Q4 2018 and held it in 7 quarters.
  • RTW Investments's Sage Therapeutics position peaked at $113M in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2025.

Based on RTW Investments's 13F filing for Q1 2025, filed 15 May 2025.